N-Terminal Pro-BNP in Acute Coronary Syndrome Patients with ST Elevation versus Non ST Elevation Myocardial Infarction
- 1 Department of Biochemistry King Fahed Specialist Hospital, KSA.
- 2
- 3
- 4
Abstract
The study aimed to evaluate the differences in secretion of NT-proBNP and conventional cardiac markers in patients with STE-ACS vs NSTE-ACS as a trial to solve the dilemma of the early detection of myocardial ischemia in NSTE-ACS. Sixty two patients with acute coronary syndrome (ACS) divided into 2 groups according to ECG: group1 with elevated ST segment in ECG (STE-ACS) and group 2 with non elevated ST segment (NSTE-ACS).Twenty healthy subjects with matched age and sex were enrolled as control group in this study. In the sera of all subjects, levels of NT –proBNP, CK-MB and troponin-T were measured by different kits. CK-MB and TnT were both significantly higher in STE-ACS patients compared to NSTE-ACS patients. Conversely, NT-proBNP was significantly higher in NSTE-ACS patients than STE-ACS especially within 4 hours from onset of chest pain. Comparison between NT-proBNP, TnT and CK-MB levels by ROC curves revealed area under the curves = 0.68, 0.31, 0.17 respectively. NT-proBNP at cutoff 415 pg/mL in NSTE-ACS patients had higher sensitivity and specificity (92%, 39%; respectively) than other markers that will help in earl diagnosis of NSTE-ACS.
- Y. Seino, A. Ogawa, T .Yamashita, M. Fukushima, K. Ogata, H. Fukumoto, T. Takano, “Application of NT- proBNP and BNP measurements in cardiac care: A more discerning marker for the detection and evaluation of heart failure”, Eur. J. Heart Fail., Vol. 6, No. 3, 2004, pp 295-300.
- N. van der Burg-de Graauw, C.M Cobbaert , C .J Middelhoff , T.A Bantje, .van Guldener, “The additive value of N-terminal pro-B-type natriuretic peptide testing at the emergency department in patients with acute dyspnea”, Eur. J. Intern. Med., Vol. 20, No. 3, 2009, pp 301-6.
- P.R Fox, M.A Oyama, C. Reynolds, J.E Rush, T.C Defrancesco, B.W Keene, C.E Atkins, K.A Macdonald , K. ESchober , J.D Bonagura , R.L Stepien , H.B Kellihan, T.P Nguyenba, L.B Lehmkuhl, B.K Lefbom, N.S Moise , D.F Hogan, “Utility of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) to distinguish between congestive heart failure and non-cardiac causes of acute dyspnea in cats”, J Vet Cardiol., Vol. 11, Suppl 1, 2009, pp S51-61
- L. Lorgis, M. Zeller, G. Dentan, P. Sicard, P. Buffet , I. L’Huillier, J. C. Beer, M. Vincent-Martin, H. Makki, P .Gambert, Y. Cottin, “RICO Survey Working Group: Prognostic value of N-terminal pro-brain natriuretic peptide in elderly people with acute myocardial infarction: prospective observational study”, BMJ, Vol. 6, No.338, 2009, pp b1605.
- M. Heringlake, T. Kox, J. Poeling, S. Klaus, T. Hanke, N. Franz, F. Eberhardt, H. Heinze, F. P. Armbruster, L. Bahlmann, “The effects of physical exercise on plasma levels of relaxin, NTproANP, and NTproBNP in patients with ischemic heart disease”, Eur. J. Med. Res., Vol. 14, No. 3, 2009, pp 106-12.
- O. Bruder, C. Jensen, M. Jochims, M. Farazandeh, J. Barkhausen, T. Schlosser, G.V Sabin, P. Hunold, “Relation of B-type natriuretic peptide (BNP) and infarct size as assessed by contrast-enhanced MRI”, Int. J. Cardiol., Vol. 24,No. 144;1 ,2009, pp 53-8.
- S. Garcia, M. S Akbar, S.SAli , F. Kamdar, M.Y Tsai, D.A Duprez, “N-terminal pro B-type natriuretic peptide predicts mortality in patients with left ventricular hypertrophy”, Int J Cardiol., Vol.143, No. 3, 2009, pp 349-52.
- J. Alpert, K. Thygesen, E. Antman, J.P Bassand, “Myocardial infarction redefined: A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction”, J Am Coll Cardiol., Vol.36, 2000, pp 959-969.
- E. Braunwald, E .Antman, J. Beasley, R.M Califf, M.D Cheitlin, J.S Hochman, R.H Jones, D .Kereiakes, et al., “ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina)”, J Am Coll Cardiol., Vol. 36, 2000, pp 970-1062